We searched PubMed (from 1966 to Oct 25, 2016), Embase (from 1980 to Oct 25, 2016), and the Cochrane Library (April, 1996, to Oct 25, 2016) for relevant titles using the terms “amyotrophic lateral sclerosis”, “motor neuron disease”, or “primary lateral sclerosis” in combination with “pain”, “sensory symptoms”, “cramps”, “pain therapy”, and “opioids”. Further material was gathered from reference lists, review articles, and major textbook chapters. We also included abstracts and reports from
ReviewPain in amyotrophic lateral sclerosis
Introduction
Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disease with a fatal outcome, typically within 2–4 years from onset.1 The ALS degenerative process involves upper and lower motor neurons with onset usually at the bulbar or spinal levels, causing progressive loss of limb strength, dysphagia, dysarthria, and respiratory failure. Motor neuron degeneration is the predominant cause of disability in patients throughout all stages of ALS and is eventually the cause of death. However, many patients also have involvement of extramotor components, particularly the prefrontal cortex, associated with cognitive impairment or frontotemporal dementia.2, 3 Although CNS sensory structures are generally not implicated, some evidence for sensory system involvement comes from neuropathological,4, 5 imaging,6, 7 and clinical5, 8, 9 studies, as well as from rodent models of ALS.10, 11
Pain was a mainly neglected symptom in ALS until about 10 years ago,12 owing to a misconception of ALS as purely a motor disease, which led to clinicians not asking their patients about pain,12, 13 as has also been the case for other non-motor symptoms. However, in the past decade, the variability of ALS between affected individuals has clearly emerged, and among the wide range of neurological defects and adjunctive manifestations that have been investigated, several studies have focused on pain in ALS,13, 14, 15, 16, 17, 18 confirming earlier observations.19, 20, 21 Furthermore, pain in ALS has been considered, mostly from a therapeutic point of view, in the main guidelines on ALS treatment,22, 23 and has also been assessed in a Cochrane review.24 Nevertheless, the incidence, severity, distribution, underlying mechanisms, and treatment of pain in ALS have not been completely addressed, mainly because of the absence of a standardised method for diagnosing pain, the scarcity of data on pain determinants, and confounding variables.
The importance of identification and assessment of pain in patients with ALS cannot be overlooked. Pain has profound detrimental effects on the quality of life of patients with ALS and their caregivers,14, 18, 25 and initial indications suggest that it could have prognostic significance.26, 27 Different types of pain might arise from different underlying mechanisms—eg, primary causes of pain, such as neuropathic pain, could arise from the impairment of somatosensory pathways, whereas secondary causes of pain, due to the effects of tissue damage, are mainly nociceptive—and understanding the pathophysiology of pain in ALS would be relevant to determine the best treatments for individual patients.
In this Review, we summarise the current understanding of pain in patients with ALS and explore potential directions for future research. We briefly describe the epidemiology of pain in patients with ALS, before outlining the key clinical characteristics, including the association between pain and other comorbidities. We also discuss potential underlying mechanisms, with assessment of the evidence for neuropathic, nociceptive, and central sensitisation origins of pain for this disease. Finally, we review existing management strategies and emphasise the need for more rigorous studies of treatments for pain in patients with ALS.
Section snippets
Epidemiology of pain in ALS
There are few systematic studies on pain in patients with ALS and only three longitudinal studies (appendix p 2). The reported frequency of pain in ALS varies greatly, from less than 15%20, 28, 29 up to 85%.14, 17, 25, 30, 31, 32, 33 This large variability can be explained by the different study designs and settings, and the different instruments used to identify and measure pain. Moreover, the number of patients with ALS included in these studies is often small (study numbers range from seven33
Assessment of pain in the clinical setting
Despite the high frequency of pain in ALS and its negative effect on patients' quality of life, both the Practice Parameters of the American Academy of Neurology22 and the European Guidelines on the Clinical Management of ALS23 discuss its treatment for patients with ALS but do not suggest proactive screening of this symptom during the course of the disease. In the results of an online survey of ALS clinics in the USA, in which only a third of physicians responded,37 92% stated that pain was
Characteristics of pain in ALS
In patients with ALS, great variability exists in the clinical manifestations and localisation of pain (figure), which depend on whether the pain represents primary mechanisms or results from the secondary effects of motor degeneration. Pain severity and the presence and nature of pain over the disease course also vary between individuals, and in some cases pain is evident before the presence of motor symptoms. Pain in ALS can be acute or chronic (when continuous for 3 months or longer). In
Mechanisms of pain in ALS
In patients with ALS, the association between the unpleasant sensory and emotional experiences that pain entails and the progressive degeneration of upper and lower motor neuron degeneration along with the involvement of other nervous system structures is poorly understood. According to the cross-sectional studies discussed above, much of the chronic pain experienced by patients with ALS seems to occur as a result of the motor impairment in ALS; however, secondary pain does not seem to explain
Treatment of pain in ALS
The ultimate need of patients with ALS experiencing pain is to reduce pain intensity and, if possible, prevent it from becoming chronic. After the cause of pain has been defined, the appropriate treatments, including pharmacological and non-pharmacological interventions, should be adopted, following guidelines when available, with the aim of providing patients with personalised therapies. Pharmacological treatments (table 1) are the main approaches for neuropathic and other types of primary
Conclusions and future perspectives
Patients with ALS can experience pain as a result of various causes including reduced mobility, cramps, and spasticity. On the basis of the available published work, pain should be considered as a condition that: (1) can complicate the course of ALS in a proportion of patients that varies according to the definition of pain used and the analysis, or not, of mood comorbidities; (2) can occur throughout the course of the disease; (3) commonly has a mild intensity, with the possible exception of
Search strategy and selection criteria
References (111)
- et al.
Amyotrophic lateral sclerosis
Lancet
(2011) - et al.
Chronic pain in persons with neuromuscular disease
Arch Phys Med Rehabil
(2005) - et al.
Attitude of outpatients with neuromuscular diseases in Japan to pain and use of analgesics
J Neurol Sci
(2008) - et al.
The cerebral signature for pain perception and its modulation
Neuron
(2007) - et al.
Ventilator dependence and expressions of need: a study of patients with amyotrophic lateral sclerosis in Japan
Soc Sci Med
(2006) The quality of care and symptom control—the effects on the terminal phase of ALS/MND
J Neurol Sci
(1996)- et al.
Predictors and correlates of interest in assisted suicide in the final month of life among ALS patients in Oregon and Washington
J Pain Symptom Manage
(2002) - et al.
Clinical indicators of ‘nociceptive’, ‘peripheral neuropathic’ and ‘central’ mechanisms of musculoskeletal pain. A Delphi survey of expert clinicians
Man Ther
(2010) - et al.
Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes
Lancet Neurol
(2014) - et al.
Amyotrophic lateral sclerosis care in Italy: a nationwide study in neurological centers
J Neurol Sci
(2001)
Interdisciplinary palliative care, including massage, in treatment of amyotrophic lateral sclerosis
J Bodyw Mov Ther
18F-FDG-PET correlates of cognitive impairment in ALS
Neurology
The role of APOE in the occurrence of frontotemporal dementia in amyotrophic lateral sclerosis
JAMA Neurol
Absence of SOD1 gene abnormalities in familial amyotrophic lateral sclerosis with posterior column involvement without Lewy-body-like hyaline inclusions
Acta Neuropathol
Sporadic motor neuron disease with severe sensory neuronopathy
Acta Neuropathol
7-T MRI of the spinal cord can detect lateral corticospinal tract abnormality in amyotrophic lateral sclerosis
Muscle Nerve
Electrophysiological and spinal imaging evidences for sensory dysfunction in amyotrophic lateral sclerosis
BMJ Open
Amyotrophic lateral sclerosis with sensory neuropathy: part of a multisystem disorder?
J Neurol Neurosurg Psychiatry
Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study
J Neurol Neurosurg Psychiatry
Sensory involvement in the SOD1-G93A mouse model of amyotrophic lateral sclerosis
Exp Mol Med
ALS mouse model SOD1G93A displays early pathology of sensory small fibers associated to accumulation of a neurotoxic splice variant of peripherin
Hum Mol Genet
Reassessing received wisdom in ALS—pain is common when studied systematically
Eur J Neurol
Pain in amyotrophic lateral sclerosis: a neglected aspect of disease
Neurol Res Int
Pain in amyotrophic lateral sclerosis: a population-based controlled study
Eur J Neurol
Prevalence and characteristics of pain in early and late stages of ALS
Amyotroph Lateral Scler Frontotemporal Degener
Is there pain with neuropathic characteristics in patients with amyotrophic lateral sclerosis? A cross-sectional study
Palliat Med
Pain in amyotrophic lateral sclerosis: Patient and physician perspectives and practices
Amyotroph Lateral Scler Frontotemporal Degener
Patient-reported problematic symptoms in an ALS treatment trial
Amyotroph Lateral Scler Frontotemporal Degener
Chronic pain syndrome in amyotrophic lateral sclerosis
Arch Neurol
Amyotrophic lateral sclerosis. Clinical analysis of 78 cases from Fortaleza (northeastern Brazil)
Arquivos de neuro-psiquiatria
Correlates of suffering in amyotrophic lateral sclerosis
Neurology
Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurology
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)—revised report of an EFNS task force
Eur J Neurol
Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease
Cochrane Database Syst Rev
The evaluation of pain in amyotrophic lateral sclerosis: a case controlled observational study
Amyotroph Lateral Scler Frontotemporal Degener
Nonmotor involvement in amyotrophic lateral sclerosis: new insight from nerve and vessel analysis in skin biopsy
Neuropathol Appl Neurobiol
Sensory and autonomic nervous system dysfunction in amyotrophic lateral sclerosis
Neuropathol Appl Neurobiol
Small-fibre neuropathy related to bulbar and spinal-onset in patients with ALS
J Neurol
Amyotrophic lateral sclerosis causes small fiber pathology
Eur J Neurol
Characteristics of pain in amyotrophic lateral sclerosis
Brain Behav
Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study
Funct Neurol
Survival analysis of Irish amyotrophic lateral sclerosis patients diagnosed from 1995–2010
PLoS One
Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression
Nat Biotechnol
Subjective experience and coping in ALS
Amyotroph Lateral Scler Other Motor Neuron Disord
A qualitative study of multidisciplinary ALS clinic use in the United States
Amyotroph Lateral Scler Frontotemporal Degener
Diagnosis of neuropathic pain: challenges and possibilities
Expert Opin Med Diagn
Is there pain with neuropathic characteristics in patients with amyotrophic lateral sclerosis? A cross-sectional study
Palliat Med
Natural history of muscle cramps in amyotrophic lateral sclerosis
Muscle Nerve
Muscle cramps
Muscle Nerve
Clinical practice. Chronic pruritus
N Engl J Med
Cited by (86)
Palliative Care in Amyotrophic Lateral Sclerosis
2023, Journal of Pain and Symptom ManagementAnti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications
2024, Therapeutic Advances in Endocrinology and MetabolismAmyotrophic Lateral Sclerosis and Pain: A Narrative Review from Pain Assessment to Therapy
2024, Behavioural NeurologyFrom Bench to Bedside: Unveiling the Effects of Phloroglucinol as a Promising Neuroprotective Agent in the Battle Against Neurodegenerative Disorders
2024, Current Behavioral Neuroscience ReportsCombination Drug Therapy for the Management of Chronic Neuropathic Pain
2023, Biomolecules